Hämophilie-Behandlung in Österreich
Christoph Male(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Ingrid Pabinger(Medical University of Vienna), Stephan Puchner(Vienna General Hospital), Eva Wissmann(Universitätsklinik für Kinder und Jugendpsychiatrie), Richard Crevenna(Medical University of Vienna), Alexander Haushofer(Klinikum Wels-Grieskirchen), Gerhard Schuster(Austrian Red Cross), Sabine Eichinger(Medical University of Vienna), Joachim Rettl(Klinikum Klagenfurt), Werner Streif(Innsbruck Medical University), Michael Sohm(Universitätsklinikum St. Pölten), Karl Zwiauer(University of Vienna), Barbara Wagner(Endometriosis UK), Thomas Schindl, Clemens Feistritzer(Scripps Research Institute), Katharina Thom(Medical University of Vienna), Andreas Kurringer(Bundeswehrzentralkrankenhaus Koblenz), Peter Neumeister(Medical University of Graz), Rudolf Schwarz(Universität Hamburg), Robert Füller, Cihan Ay(University of North Carolina at Chapel Hill)
Cited by 4
Related Papers
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
|New England Journal of Medicine|2021|2.3k
High Plasma Levels of Factor VIII and the Risk of Recurrent Venous Thromboembolism
|New England Journal of Medicine|2000|765
Increased fetal loss in women with heritable thrombophilia
|The Lancet|1996|677
Osteosarcoma Relapse After Combined Modality Therapy: An Analysis of Unselected Patients in the Cooperative Osteosarcoma Study Group (COSS)
|Journal of Clinical Oncology|2005|654